IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,331,241 | +13.8% | 690,724 | +2.9% | 0.01% | +20.0% |
| Q2 2023 | $27,534,330 | +17.0% | 671,078 | +1.9% | 0.01% | 0.0% |
| Q1 2023 | $23,533,574 | -2.6% | 658,466 | +2.9% | 0.01% | 0.0% |
| Q4 2022 | $24,161,054 | -12.4% | 639,689 | +2.6% | 0.01% | -16.7% |
| Q3 2022 | $27,583,000 | +19.1% | 623,640 | -0.3% | 0.01% | +20.0% |
| Q2 2022 | $23,155,000 | -3.6% | 625,472 | -3.6% | 0.01% | +25.0% |
| Q1 2022 | $24,020,000 | +19.4% | 648,534 | -1.9% | 0.00% | +33.3% |
| Q4 2021 | $20,112,000 | -8.5% | 660,890 | +0.8% | 0.00% | -25.0% |
| Q3 2021 | $21,984,000 | -17.9% | 655,421 | -2.4% | 0.00% | -20.0% |
| Q2 2021 | $26,789,000 | -29.2% | 671,573 | -20.2% | 0.01% | -28.6% |
| Q1 2021 | $37,818,000 | -18.9% | 841,145 | +1.9% | 0.01% | -22.2% |
| Q4 2020 | $46,656,000 | +18.2% | 825,174 | -0.8% | 0.01% | 0.0% |
| Q3 2020 | $39,457,000 | -19.4% | 831,536 | +0.1% | 0.01% | -25.0% |
| Q2 2020 | $48,972,000 | +24.0% | 830,597 | -0.6% | 0.01% | +9.1% |
| Q1 2020 | $39,501,000 | -18.1% | 835,493 | +4.7% | 0.01% | 0.0% |
| Q4 2019 | $48,225,000 | +0.7% | 798,287 | -0.1% | 0.01% | 0.0% |
| Q3 2019 | $47,883,000 | -7.6% | 799,258 | -0.8% | 0.01% | -8.3% |
| Q2 2019 | $51,794,000 | -2.2% | 805,897 | +23.5% | 0.01% | -7.7% |
| Q1 2019 | $52,969,000 | +51.5% | 652,571 | +0.9% | 0.01% | +30.0% |
| Q4 2018 | $34,966,000 | +5.9% | 646,790 | +1.0% | 0.01% | +25.0% |
| Q3 2018 | $33,023,000 | +27.5% | 640,212 | +3.0% | 0.01% | +14.3% |
| Q2 2018 | $25,903,000 | -2.1% | 621,643 | +3.5% | 0.01% | 0.0% |
| Q1 2018 | $26,464,000 | -10.4% | 600,357 | +2.3% | 0.01% | 0.0% |
| Q4 2017 | $29,525,000 | -1.5% | 586,982 | -0.7% | 0.01% | -12.5% |
| Q3 2017 | $29,983,000 | -5.2% | 591,378 | -4.9% | 0.01% | -11.1% |
| Q2 2017 | $31,631,000 | +36.4% | 621,816 | +7.8% | 0.01% | +28.6% |
| Q1 2017 | $23,198,000 | -5.1% | 577,066 | +12.9% | 0.01% | 0.0% |
| Q4 2016 | $24,445,000 | +31.2% | 511,088 | +0.5% | 0.01% | +16.7% |
| Q3 2016 | $18,631,000 | +39.3% | 508,484 | -11.4% | 0.01% | +50.0% |
| Q2 2016 | $13,371,000 | -40.0% | 574,085 | +4.4% | 0.00% | -42.9% |
| Q1 2016 | $22,271,000 | -33.3% | 549,914 | +1.9% | 0.01% | -36.4% |
| Q4 2015 | $33,407,000 | – | 539,426 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |